Paper Review Records
全部论文审稿周期
2 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
156
天
CPX-351: From preclinical studies to future directions
作者
A. Sperotto; G. Ciotti; M. Basso; M. Gottardi展开收起
作者单位
UOSD Terapie Cellulari – Dipartimento di Oncologia, Istituto Oncologico Veneto (IOV) – IRCCS – Padova, Italy; UOC Oncoematolgia – Dipartimento di Oncologia, Istituto Oncologico Veneto (IOV) – IRCCS – Padova, Italy; UOC Farmacia – Dipartimento di Oncologia traslazionale e dei servizi trasversali, Istituto Oncologico Veneto (IOV) – IRCCS – Padova, Italy展开收起
32
天
Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015–2025)
作者
Beliu García-Parra; Josep M. Guiu; Mónica Povedano; Pilar Modamio展开收起
作者单位
Doctoral Program in Drug Research, Development and Control, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; Clinical Neurophysiology Section – Neurology Service, Bellvitge University Hospital - Bellvitge Health Sciences Campus, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain; Clinical Pharmacy and Pharmaceutical Care Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain; Consortium of Health and Social Care of Catalonia, Barcelona, Spain; Motor Neuron Diseases Unit, Bellvitge University Hospital - Bellvitge Health Sciences Campus, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain展开收起
FAQ
CURRENT OPINION IN PHARMACOLOGY审稿要多久?
截至2026-11-19,CrushSCI 收录了 CURRENT OPINION IN PHARMACOLOGY 的 2 篇完整审稿记录。最快一篇从收稿到录用用了 32 天(Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015–2025),2025-10-08 收稿,2025-11-09 录用),最慢一篇用了 156 天;平均 94 天,中位数 94 天。样本少于 5 篇,结果仅供参考。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
